plerixafor

FDA Drug Profile — plerixafor, PLERIXAFOR

Drug Details

Generic Name
plerixafor
Brand Names
plerixafor, PLERIXAFOR
Application Number
ANDA215334
Sponsor
Amneal Pharmaceuticals LLC
NDC Codes
4
Dosage Forms
INJECTION, SOLUTION, INJECTION
Routes
SUBCUTANEOUS
Active Ingredients
PLERIXAFOR

Indications and Usage

1 INDICATIONS AND USAGE Plerixafor injection is indicated in combination with filgrastim to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma (NHL) or multiple myeloma (MM). Plerixafor injection, a hematopoietic stem cell mobilizer, is indicated in combination with filgrastim to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma or multiple myeloma. ( 1 )